Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-20-000582
Filing Date
2020-03-23
Accepted
2020-03-20 21:37:52
Documents
78
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K embi_10k.htm 10-K 1311007
2 EX-23.1 embi_ex231.htm EX-23.1 1503
3 CERTIFICATION embi_ex311.htm EX-31.1 7696
4 CERTIFICATION embi_ex312.htm EX-31.2 7681
5 CERTIFICATION embi_ex321.htm EX-32.1 3106
6 CERTIFICATION embi_ex322.htm EX-32.2 3029
  Complete submission text file 0001640334-20-000582.txt   7256834

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT embi-20191231.xml EX-101.INS 1360210
8 XBRL TAXONOMY EXTENSION SCHEMA embi-20191231.xsd EX-101.SCH 86217
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE embi-20191231_cal.xml EX-101.CAL 41893
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE embi-20191231_def.xml EX-101.DEF 392803
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE embi-20191231_lab.xml EX-101.LAB 891064
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE embi-20191231_pre.xml EX-101.PRE 479862
Mailing Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803
Business Address 130 NORTH MARINA DRIVE LONG BEACH CA 90803 (949) 336-3443
Emerald Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55136 | Film No.: 20733427
SIC: 2834 Pharmaceutical Preparations